Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: meta-analysis of data from genome-wide association studies
Chiara Fabbri, Katherine E. Tansey, Roy H. Perlis, Joanna Hauser, Neven Henigsberg, Wolfgang Maier, Ole N Mors, Anna Placentino, Marcella Rietschel, Daniel Souery, Gerome D. Breen, Charles J. C. Curtis, Sang‐Hyuk Lee, Stephen Newhouse, Hamel Patel, , Cathryn M. Lewis
This paper conducts a meta-analysis showing that CYP2C19 poor metabolizers have better antidepressant efficacy but similar side effects compared to extensive metabolizers.
European Neuropsychopharmacology · Jun 28, 2018Peer-reviewedGenetics